awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38114921-2C2F5064-D572-4DFA-8250-E94FE8E8A73E
Q38114921-2C2F5064-D572-4DFA-8250-E94FE8E8A73E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38114921-2C2F5064-D572-4DFA-8250-E94FE8E8A73E
Sickle cell disease: time for a closer look at treatment options?
P2860
Q38114921-2C2F5064-D572-4DFA-8250-E94FE8E8A73E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38114921-2C2F5064-D572-4DFA-8250-E94FE8E8A73E
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
d39ba8ad1f9c79cb58faec821f4e760d5664e072
P2860
Busulfan, fludarabine, and alemtuzumab conditioning and unrelated cord blood transplantation in children with sickle cell disease.